Back to GetFilings.com




Use these links to rapidly review the document
FORM 10-Q MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES INDEX



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q

(Mark One)  

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended September 30, 2004

Or

o

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                             to                              

Commission File No. 1-6639


MAGELLAN HEALTH SERVICES, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State of other jurisdiction of incorporation
or organization)
  58-1076937
(IRS Employer Identification No.)

16 Munson Road
Farmington, Connecticut

(Address of principal executive offices)

 


06032
(Zip code)

(860) 507-1900
(Registrant's telephone number, including area code)


        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o

        Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes o    No ý

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

        Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes ý    No o

        The number of shares of the registrant's Ordinary Common Stock and Multi-Vote Common Stock outstanding as of September 30, 2004 was 26,883,016 and 8,487,750 respectively.





FORM 10-Q

MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

INDEX

 
   
PART I—Financial Information:
 
Item 1:

 

Financial Statements

 

 

Condensed Consolidated Balance Sheets—December 31, 2003 and September 30, 2004

 

 

Condensed Consolidated Statements of Operations—For the Three Months and Nine Months Ended September 30, 2003 for the Predecessor Company and for the Three Months and Nine Months Ended September 30, 2004 for the Reorganized Company

 

 

Condensed Consolidated Statements of Cash Flows—For the Nine Months Ended September 30, 2003 for the Predecessor Company and for the Nine Months Ended September 30, 2004 for the Reorganized Company

 

 

Notes to Condensed Consolidated Financial Statements
 
Item 2:

 

Management's Discussion and Analysis of Financial Condition and Results of Operations
 
Item 3:

 

Quantitative and Qualitative Disclosures About Market Risk
 
Item 4:

 

Controls and Procedures

PART II—Other Information:
 
Item 1:

 

Legal Proceedings
 
Item 2:

 

Unregistered Sales of Equity Securities and Use of Proceeds
 
Item 3:

 

Defaults Upon Senior Securities
 
Item 4:

 

Submission of Matters to a Vote of Security Holders
 
Item 5:

 

Other Information
 
Item 6:

 

Exhibits
 
Signatures

2


PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.


MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except per share amounts)

 
  December 31,
2003

  September 30,
2004

 
   
  (Unaudited)

ASSETS            
Current Assets:            
  Cash and cash equivalents   $ 206,948   $ 313,890
  Stock subscriptions receivable     146,871    
  Accounts receivable, less allowance for doubtful accounts of $5,178 at December 31, 2003 and $2,690 at September 30, 2004     83,919     92,896
  Restricted cash, investments and deposits     161,923     179,044
  Other current assets     30,562     11,831
   
 
    Total current assets     630,223     597,661
Property and equipment, net     122,082     112,099
Investments in unconsolidated subsidiaries     13,034     15,773
Other long-term assets     18,334     23,487
Goodwill     450,244     450,244
Other intangible assets, net     58,100     47,717
   
 
    $ 1,292,017   $ 1,246,981
   
 
LIABILITIES AND STOCKHOLDERS' EQUITY            
Current Liabilities:            
  Accounts payable   $ 23,355   $ 16,810
  Accrued liabilities     205,868     170,837
  Medical claims payable     177,141     200,891
  Current maturities of long-term debt and capital lease obligations     24,785     23,543
  Debt paid upon consummation of the Plan     92,382    
   
 
    Total current liabilities     523,531     412,081
Long-term debt and capital lease obligations     376,532     360,308
Deferred credits and other long-term liabilities     1,802     1,751
Minority interest     2,241     2,990
Stockholders' Equity:            
  Preferred stock, par value $0.01 per share; Authorized—10,000 shares—Issued and outstanding—none at December 31, 2003 and September 30, 2004        
  Ordinary common stock, par value $0.01 per share; Authorized—100,000 shares—26,552 shares issued and outstanding at December 31, 2003 and 26,883 shares issued and outstanding at September 30, 2004     265     269
  Multi-Vote common stock, par value $0.01 per share; Authorized—40,000 shares—8,553 shares issued and outstanding at December 31, 2003 and 8,488 shares issued and outstanding at September 30, 2004     86     85
Other Stockholders' Equity:            
  Additional paid-in capital     379,067     393,086
  Retained earnings         67,918
  Warrants outstanding     8,493     8,493
   
 
    Total stockholders' equity     387,911     469,851
   
 
    $ 1,292,017   $ 1,246,981
   
 

See accompanying notes.

3



MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

 
  Predecessor Company
  Reorganized Company
  Predecessor Company
  Reorganized Company
 
 
  Three Months Ended
September 30, 2003

  Three Months Ended
September 30, 2004

  Nine Months Ended
September 30, 2003

  Nine Months Ended
September 30, 2004

 
Net revenue   $ 373,707   $ 457,954   $ 1,172,951   $ 1,350,234  
   
 
 
 
 
Cost and expenses:                          
  Salaries, cost of care and other operating expenses     331,587     394,374     1,052,002     1,182,181  
  Equity in earnings of unconsolidated subsidiaries     (1,362 )   (1,863 )   (3,161 )   (5,561 )
  Depreciation and amortization     11,593     10,712     36,265     31,478  
  Goodwill impairment charges     28,780         28,780      
  Interest expense (Contractual interest of $26,392 and $79,610 for the three months and nine months ended September 30, 2003, respectively)     4,748     9,109     31,474     27,499  
  Interest income     (670 )   (1,760 )   (2,173 )   (3,593 )
  Reorganization expense, net (See Note A)     4,540         32,245      
  Stock compensation expense         2,580         15,898  
  Special charges     3,230     1,770     5,322     4,304  
   
 
 
 
 
      382,446     414,922     1,180,754     1,252,206  
   
 
 
 
 
Income (loss) from continuing operations before income taxes and minority interest     (8,739 )   43,032     (7,803 )   98,028  
Provision for income taxes     20,825     15,712     24,258     28,976  
   
 
 
 
 
Income (loss) from continuing operations before minority interest     (29,564 )   27,320     (32,061 )   69,052  
Minority interest, net     3     157     170     526  
   
 
 
 
 
Income (loss) from continuing operations     (29,567 )   27,163     (32,231 )   68,526  
   
 
 
 
 
Discontinued operations:                          
  Income (loss) from discontinued operations(1)     (25,233 )   (579 )   (25,849 )   (509 )
  Income (loss) on disposal of discontinued operations(2)     4,271     (28 )   6,421     (99 )
  Reorganization benefit, net(3) (See Note A)     314         3,481      
   
 
 
 
 
      (20,648 )   (607 )   (15,947 )   (608 )
   
 
 
 
 
Net income (loss)     (50,215 )   26,556     (48,178 )   67,918  
   
 
 
 
 
Preferred dividends (Contractual dividends of $1,216 and $3,552 for the three months and nine months ended September 30, 2003, respectively)             884      
Amortization of redeemable preferred stock issuance costs and other             171      
Preferred stock reorganization items, net (See Note A)             2,668      
   
 
 
 
 
Income (loss) available to common stockholders     (50,215 )   26,556     (51,901 )   67,918  
Other comprehensive income                  
   
 
 
 
 
Comprehensive income (loss)   $ (50,215 ) $ 26,556   $ (51,901 ) $ 67,918  
   
 
 
 
 

4


Weighted average number of common shares outstanding—basic (See Note E)     35,319     35,371     35,300     35,365  
   
 
 
 
 
Weighted average number of common shares outstanding—diluted (See Note E)     35,319     36,594     35,300     36,235  
   
 
 
 
 
Income (loss) per common share available to common stockholders—basic:                          
      Income (loss) from continuing operations   $ (0.84 ) $ 0.77   $ (1.02 ) $ 1.94  
   
 
 
 
 
      Income (loss) from discontinued operations   $ (0.58 ) $ (0.02 ) $ (0.45 ) $ (0.02 )
   
 
 
 
 
      Net income (loss)   $ (1.42 ) $ 0.75   $ (1.47 ) $ 1.92  
   
 
 
 
 
Income (loss) per common share available to common stockholders—diluted:                          
      Income (loss) from continuing operations   $ (0.84 ) $ 0.74   $ (1.02 ) $ 1.89  
   
 
 
 
 
      Income (loss) from discontinued operations   $ (0.58 ) $ (0.01 ) $ (0.45 ) $ (0.02 )
   
 
 
 
 
      Net income (loss)   $ (1.42 ) $ 0.73   $ (1.47 ) $ 1.87  
   
 
 
 
 

(1)
Net of income tax provision (benefit) of $285 and $(235) for the three months ended September 30, 2003 and 2004, respectively, and $(148) and $(213) for the nine months ended September 30, 2003 and 2004, respectively.

(2)
Net of income tax benefit of $(270) and $(19) for the three months ended September 30, 2003 and 2004, respectively, and $(322) and $(41) for the nine months ended September 30, 2003 and 2004, respectively.

(3)
Net of income tax benefit of $(26) for the three and nine months ended September 30, 2003.

See accompanying notes.

5



MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 
  Predecessor Company
  Reorganized Company
 
 
  Nine Months Ended
September 30, 2003

  Nine Months Ended
September 30, 2004

 
Cash flows from operating activities:              
  Net income (loss)   $ (48,178 ) $ 67,918  
  Adjustments to reconcile net income (loss) to net cash from operating activities:              
    (Gain) loss on sale of assets     (4,460 )   141  
    Depreciation and amortization     36,265     31,478  
    Goodwill impairment charges     28,780      
    Equity in earnings of unconsolidated subsidiaries     (3,161 )   (5,561 )
    Non-cash reorganization expense     12,464      
    Non-cash interest expense     3,668     1,197  
    Non-cash stock compensation expense         13,021  
    Cash flows from changes in assets and liabilities:              
      Accounts receivable, net     14,233     (8,977 )
      Restricted cash, investments and deposits     7,503     (17,121 )
      Net cash flows related to unconsolidated subsidiaries     (16 )   2,822  
      Income taxes payable and deferred income taxes     1,503      
      Other assets     (12,795 )   19,803  
      Accounts payable and accrued liabilities     110,972     (41,576 )
      Medical claims payable     (7,618 )   23,750  
      Other liabilities     (1,063 )   (51 )
      Minority interest, net of dividends paid     231     749  
      Other     2,151     718  
   
 
 
Total adjustments     188,657     20,393  
   
 
 
    Net cash from operating activities     140,479     88,311  
   
 
 
Cash flows from investing activities:              
  Capital expenditures     (15,228 )   (12,445 )
  Acquisitions and investments in businesses     (3,731 )    
  Proceeds from sale of assets, net of transaction costs     2,588     2,302  
   
 
 
    Net cash from investing activities     (16,371 )   (10,143 )
   
 
 
Cash flows from financing activities:              
  Proceeds from issuance of new equity, net of issuance costs         147,871  
  Proceeds from issuance of debt, net of issuance costs     49     92,806  
  Payments on long-term debt         (203,632 )
  Payments on capital lease obligations     (2,556 )   (8,271 )
  Proceeds from stock issued under employee stock purchase plan     25      
   
 
 
    Net cash from financing activities     (2,482 )   28,774  
   
 
 
Net increase in cash and cash equivalents     121,626     106,942  
Cash and cash equivalents at beginning of period     62,488     206,948  
   
 
 
Cash and cash equivalents at end of period   $ 184,114   $ 313,890  
   
 
 

See accompanying notes.

6



MAGELLAN HEALTH SERVICES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2004

(Unaudited)

NOTE A—General

Basis of Presentation

        The accompanying unaudited condensed consolidated financial statements of Magellan Health Services, Inc., a Delaware corporation ("Magellan"), include the accounts of Magellan, its majority owned subsidiaries, and all variable interest entities ("VIEs") for which Magellan is the primary beneficiary (together with Magellan, the "Company"). The financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the Securities and Exchange Commission's (the "SEC") instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring adjustments considered necessary for a fair presentation, have been included. The results of operations for the three-month period and nine-month period ended September 30, 2004 are not necessarily indicative of the results to be expected for the full year. All intercompany accounts and transactions have been eliminated in consolidation.

        These unaudited condensed consolidated financial statements should be read in conjunction with the Company's audited consolidated financial statements for the year ended December 31, 2003 and the notes thereto, which are included in the Company's Annual Report on Form 10-K filed with the SEC on March 30, 2004.

Recent Events

        On January 5, 2004 (the "Effective Date"), the Company's plan of reorganization (the "Plan") became effective and the Company emerged from bankruptcy. The principal terms of the Plan, including the treatment afforded under the Plan to the holders of the Company's pre-existing indebtedness and other liabilities and equity interests, are summarized in Item 1 of the Company's Annual Report on Form 10-K for the year ended December 31, 2003, previously filed with the SEC. In the discussion herein of periods prior to the Effective Date, references to such pre-existing indebtedness and other securities shall have the meaning set forth therein. The Company, as of December 31, 2003 and subsequently, is referred to herein as the "Reorganized Company" and, in connection with prior periods, is referred to herein as the "Predecessor Company".

        Giving effect to the Plan, the Company continued, in its previous organizational form, to conduct its business as previously conducted, with the same assets in all material respects (except for cash to be distributed under the Plan to former creditors of the Company), but the Company was recapitalized. Specifically, Onex Corporation, a Canadian corporation, through an affiliate (together, "Onex"), invested approximately $102.1 million in the equity of Magellan in the form of Multi-Vote Common Stock (the "Onex Investment"), which entitles it to a fifty percent voting interest in all matters that come before Magellan's stockholders, with certain exceptions. Pursuant to the Plan, the Company received additional equity infusions totaling $63.3 million from holders of the Company's Old Subordinated Notes (the "Holders") and other general unsecured creditors (the "Other GUCs"), which elected to purchase common stock in the form of Ordinary Common Stock of the Company in an equity offering. Onex's equity investment included initial capital contributions to the Company pursuant to the Plan of $86.7 million and additional capital contributions of $15.4 million under its commitment to fund the election by creditors to receive cash in lieu of common stock distributions in satisfaction of

7



their claims (the "Cash-Out Election") by purchasing that amount of shares of Multi-Vote Common Stock equal to the amount of shares of Ordinary Common Stock cashed out by the Holders and the Other GUCs pursuant to the Cash-Out Election. Capital contributions of $146.9 million, net of approximately $3.1 million of issuance costs and excluding funds received from the Cash-Out Election, are reflected as "Stock subscriptions receivable" in the accompanying condensed consolidated balance sheet as of December 31, 2003. Of the funds received by the Company pursuant to the Cash-Out Election, $15.2 million are included in "Other current assets" in the accompanying condensed consolidated balance sheet as of December 31, 2003, with the remaining amount of $0.2 million being recorded by the Company and paid by Onex subsequent to March 31, 2004. All previously existing equity interests in Magellan were cancelled as of the Effective Date.

        Also pursuant to the Plan, the Company entered into a new credit agreement with Deutsche Bank AG (the "Credit Agreement"), issued $233.5 million of Series A Senior Notes and $7.1 million of Series B Senior Notes (together, the "Senior Notes"), renewed its agreement with Aetna, Inc. ("Aetna") to manage the behavioral healthcare of members of Aetna's healthcare programs and issued to Aetna an interest bearing note in the amount of $48.9 million (the "Aetna Note"). The Company's secured bank loans under its old credit agreement, as existing before the Effective Date (the "Old Credit Agreement"), were paid in full, and other then existing indebtedness (i.e., two classes of notes and general unsecured creditor claims) was cancelled as of the Effective Date.

        The discussion above represents a summary of certain transactions which occurred as of and subsequent to the Effective Date pursuant to the Plan. Please refer to the Company's Annual Report on Form 10-K for the year ended December 31, 2003 for a more detailed description of the recapitalization of the Company and other transactions pursuant to the Plan.

Accounting Impact of Chapter 11 Filing

        In connection with the consummation of the Plan, the Company adopted the fresh start reporting provisions of American Institute of Certified Public Accountants ("AICPA") Statement of Position 90-7, "Financial Reporting by Entities in Reorganization under the Bankruptcy Code" ("SOP 90-7") with respect to its financial reports, which required the Company to restate its assets and liabilities to their fair values based upon the provisions of the Plan and certain valuations which the Company made in connection with the implementation of the Plan. The Company applied the fresh start reporting provisions as of December 31, 2003. Upon adoption of fresh start reporting, the Company created, in substance, per SOP 90-7, a new reporting entity, which is referred to herein as the "Reorganized Company". Accordingly, the unaudited condensed consolidated statements of operations for the three months and nine months ended September 30, 2004 and statement of cash flows for the nine months ended September 30, 2004 are not comparable with the unaudited condensed consolidated statements of operations for the three months and nine months ended September 30, 2003 and statement of cash flows for the nine months ended September 30, 2003. Therefore, all statements of operations data for the three months and nine months ended September 30, 2004 and statement of cash flows data for the nine months ended September 30, 2004 have been disclosed herein as results of operations and cash flows of the Reorganized Company, and all statements of operations data for the three months and nine months ended September 30, 2003 and statement of cash flows data for the nine months ended September 30, 2003 have been disclosed herein as results of operations and cash flows of the Predecessor Company. Balance sheet data as of December 31, 2003 and September 30, 2004 presented herein represents balances of the Reorganized Company. All references to the Company with respect to disclosures of amounts recorded for the three months and nine months ended September 30, 2003 in relation to income statement items and recorded for the nine months ended September 30, 2003 in relation to cash flow items pertain to the Predecessor Company. All references to the Company with respect to disclosures of amounts recorded for the three months and nine months ended September 30, 2004 or to be recorded subsequent to September 30, 2004 in relation to income statement items and

8



recorded for the nine months ended September 30, 2004 or recorded subsequent to September 30, 2004 in relation to cash flow items pertain to the Reorganized Company.

        The unaudited condensed consolidated statements of operations for the three months and nine months ended September 30, 2003 and statement of cash flows for the nine months ended September 30, 2003 in this Form 10-Q were prepared in accordance with SOP 90-7, as the Predecessor Company was under bankruptcy protection during those periods. As such, the Predecessor Company's unaudited condensed consolidated statements of operations for the three months and nine months ended September 30, 2003 and statement of cash flows for the nine months ended September 30, 2003 distinguished transactions and events that were directly associated with the reorganization from the Predecessor Company's ongoing operations. In accordance with SOP 90-7, the write-off of deferred financing fees associated with the Old Senior Notes and the Old Subordinated Notes, as well as certain professional fees and expenses and other amounts directly associated with the bankruptcy process, were recorded as reorganization expenses, and are included in the unaudited condensed consolidated statement of operations caption "Reorganization expense, net" for the three months and nine months ended September 30, 2003.

        The following table summarizes reorganization expense (benefit) for the three months and nine months ended September 30, 2003 (in thousands):

 
  Predecessor Company
 
 
  Three Months Ended
September 30, 2003

  Nine Months Ended
September 30, 2003

 
Continuing operations:              
  Deferred financing costs   $   $ 18,459  
  Professional fees and expenses     7,112     17,019  
  Net benefit from lease rejections     (331 )   (599 )
  Net benefit from resolution of claims through Bankruptcy Court proceedings     (1,920 )   (1,920 )
  Interest income     (321 )   (714 )
   
 
 
    $ 4,540   $ 32,245  
   
 
 
Discontinued operations, before taxes:              
  Net benefit from lease rejections     (259 )   (3,426 )
  Net benefit from resolution of claims through Bankruptcy Court proceeding     (29 )   (29 )
   
 
 
    $ (288 ) $ (3,455 )
   
 
 

        In accordance with SOP 90-7, the Predecessor Company's redeemable preferred stock was recorded at the amount expected to be allowed as a claim by the Bankruptcy Court. Accordingly, during the three months ended March 31, 2003, the Predecessor Company recorded a net $2.7 million adjustment, which was mainly composed of the write-off of unamortized issuance costs related to the redeemable preferred stock. Such amount is reflected in "Preferred stock reorganization items, net" in the accompanying unaudited condensed consolidated statements of operations for the nine months ended September 30, 2003.

9



NOTE B—Summary of Significant Accounting Policies

Review of Significant Accounting Policies

        The Reorganized Company has adopted the same accounting policies as the Predecessor Company with the exception of the date on which the Reorganized Company intends to perform its annual goodwill impairment test (see "Goodwill" below).

Use of Estimates

        The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant estimates of the Company include, among other things, accounts receivable realization, valuation allowances for deferred tax assets, valuation of goodwill and other intangible assets, medical claims payable and legal liabilities. Actual results could differ from those estimates.

Managed Care Revenue

        Managed care revenue is recognized over the applicable coverage period on a per member basis for covered members. Managed care risk revenue earned by the Predecessor Company for the three months and nine months ended September 30, 2003 approximated $325.3 million and $1,008.4 million, respectively. Managed care risk revenue earned by the Reorganized Company for the three months and nine months ended September 30, 2004 approximated $402.8 million and $1,185.8 million, respectively.

        The Company has the ability to earn performance-based revenue, primarily under certain non-risk contracts. Performance-based revenue generally is based on the ability of the Company to manage care for its administrative services only ("ASO") clients below specified cost targets. For each such contract, the Company estimates and records performance-based revenue after considering the relevant contractual terms and the data available for the performance-based revenue calculation. Pro-rata performance-based revenue is recognized on an interim basis pursuant to the rights and obligations of each party upon termination of the contracts. The Predecessor Company recognized performance-based revenue of approximately $1.3 million and $5.6 million for the three months and nine months ended September 30, 2003, respectively. The Reorganized Company recognized performance-based revenue of approximately $1.9 million and $5.6 million for the three months and nine months ended September 30, 2004, respectively.

Significant Customers

        Net revenues from two customers each exceeded ten percent of consolidated net revenues in each of the three-month and nine-month periods ended September 30, 2003 and 2004. In addition, the Company has a significant concentration of business from individual customers which are part of the Pennsylvania Medicaid program.

        Net revenue from Aetna earned by the Predecessor Company approximated $48.1 million and $144.8 million for the three months and nine months ended September 30, 2003, respectively. Net revenue from Aetna earned by the Reorganized Company approximated $58.4 and $170.4 million for the three months and nine months ended September 30, 2004, respectively. The current Aetna contract ext